Peter Nilsson
391 – 400 of 858
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
(
- Contribution to journal › Article
-
Mark
Cystatin C and risk of diabetes and the metabolic syndrome - Biomarker and genotype association analyses
(
- Contribution to journal › Article
-
Mark
Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes : A meta-analysis
(
- Contribution to journal › Article
-
Mark
Low-level exposure to lead, blood pressure, and hypertension in a population-based cohort
(
- Contribution to journal › Article
-
Mark
Atrial Natriuretic Peptide in the high normal range is associated with lower prevalence of insulin resistance.
(
- Contribution to journal › Article
-
Mark
The genetic architecture of type 2 diabetes
(
- Contribution to journal › Article
-
Mark
An obligatory role for neurotensin in high-fat-diet-induced obesity
(
- Contribution to journal › Letter
-
Mark
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function
(
- Contribution to journal › Article
-
Mark
Sixth in a series on diabetes and the heart: The cardiovascular effects of anti-diabetes drugs – an update in 2016
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study
(
- Contribution to journal › Article